666 reports of this reaction
1.9% of all ZIPRASIDONE HYDROCHLORIDE reports
#11 most reported adverse reaction
SUICIDE ATTEMPT is the #11 most commonly reported adverse reaction for ZIPRASIDONE HYDROCHLORIDE, manufactured by ROERIG. There are 666 FDA adverse event reports linking ZIPRASIDONE HYDROCHLORIDE to SUICIDE ATTEMPT. This represents approximately 1.9% of all 35,561 adverse event reports for this drug.
Patients taking ZIPRASIDONE HYDROCHLORIDE who experience suicide attempt should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SUICIDE ATTEMPT is a less commonly reported adverse event for ZIPRASIDONE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to suicide attempt, the following adverse reactions have been reported for ZIPRASIDONE HYDROCHLORIDE:
The following drugs have also been linked to suicide attempt in FDA adverse event reports:
SUICIDE ATTEMPT has been reported as an adverse event in 666 FDA reports for ZIPRASIDONE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SUICIDE ATTEMPT accounts for approximately 1.9% of all adverse event reports for ZIPRASIDONE HYDROCHLORIDE, making it a notable side effect.
If you experience suicide attempt while taking ZIPRASIDONE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.